US airstrikes hit 23 Iranian pharmaceutical and distribution companies in recent strikes.
Recent U.S. airstrikes against Iran, carried out during overnight bombings over the past few days, have damaged 23 pharmaceutical facilities, disrupted domestic drug production and threatened vital health care supply chains, according to Iran's Food and Drug Administration.
In a statement carried by Tasnim, a spokesman for the regulatory agency confirmed that the latest wave of airstrikes in the US targeted 15 drug manufacturing facilities and eight major medical distribution companies.
The official warned that the recent destruction of industrial infrastructure has created immediate bottlenecks of 37 essential medicines out of about 700 essential pharmaceutical products prescribed for national healthcare delivery.
The health authorities emphasized that ongoing attacks against special facilities threaten to cut off the supply chain of critical raw materials required in the synthesis of local medicines.
The campaign in Washington against Iranian industrial assets is increasingly targeting civilian supply lines and medical infrastructure, exacerbating public health risks across the country under the guise of military operations.